Diarrhea - Pipeline Review, H1 2019

Global Markets Direct’s, ‘Diarrhea - Pipeline Review, H1 2019’, provides an overview of the Diarrhea pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Diarrhea and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Diarrhea

- The report reviews pipeline therapeutics for Diarrhea by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved Diarrhea therapeutics and enlists all their major and minor projects

- The report assesses Diarrhea therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news related to pipeline therapeutics for Diarrhea

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of therapeutics under development for Diarrhea

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Diarrhea pipeline depth and focus of Indication therapeutics

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

Akthelia Pharmaceuticals Ltd

Albireo Pharma Inc

Allergan Plc

Ardelyx Inc

AzurRx BioPharma Inc

Bharat Biotech Ltd

Boston Pharmaceuticals Inc

Chongqing Zhifei Biological Products Co Ltd ...

Akthelia Pharmaceuticals Ltd

Albireo Pharma Inc

Allergan Plc

Ardelyx Inc

AzurRx BioPharma Inc

Bharat Biotech Ltd

Boston Pharmaceuticals Inc

Chongqing Zhifei Biological Products Co Ltd

Cosmo Pharmaceuticals NV

DiscoveryBiomed Inc

Ferring International Center SA

GP Pharm SA

Kaleido Biosciences Inc

Kuhnil Pharmaceutical Co Ltd

MyBiotics Pharma Ltd

Napo Pharmaceuticals Inc

Nippon Shinyaku Co Ltd

Novartis AG

Prokarium Ltd

Protagonist Therapeutics Inc

RaQualia Pharma Inc

RedHill Biopharma Ltd

RxBio Inc

Scandinavian Biopharma Holding AB

Synthetic Biologics Inc

Syntiron LLC

Tasly Pharmaceutical Group Co Ltd

VenatoRx Pharmaceuticals Inc

Zealand Pharma AS

Table of Contents

Table of Contents

Introduction

Diarrhea – Overview

Diarrhea – Therapeutics Development

Diarrhea – Therapeutics Assessment

Diarrhea – Companies Involved in Therapeutics Development

Diarrhea – Drug ...

Table of Contents

Introduction

Diarrhea – Overview

Diarrhea – Therapeutics Development

Diarrhea – Therapeutics Assessment

Diarrhea – Companies Involved in Therapeutics Development

Diarrhea – Drug Profiles

Diarrhea – Dormant Projects

Diarrhea – Discontinued Products

Diarrhea – Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Diarrhea, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under ...

List of Tables

Number of Products under Development for Diarrhea, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Products under Development by Companies, H1 2019

Products under Development by Universities/Institutes, H1 2019

Number of Products by Stage and Target, H1 2019

Number of Products by Stage and Mechanism of Action, H1 2019

Number of Products by Stage and Route of Administration, H1 2019

Number of Products by Stage and Molecule Type, H1 2019

Diarrhea – Pipeline by Akthelia Pharmaceuticals Ltd, H1 2019

Diarrhea – Pipeline by Albireo Pharma Inc, H1 2019

Diarrhea – Pipeline by Allergan Plc, H1 2019

Diarrhea – Pipeline by Ardelyx Inc, H1 2019

Diarrhea – Pipeline by AzurRx BioPharma Inc, H1 2019

Diarrhea – Pipeline by Bharat Biotech Ltd, H1 2019

Diarrhea – Pipeline by Boston Pharmaceuticals Inc, H1 2019

Diarrhea – Pipeline by Chongqing Zhifei Biological Products Co Ltd, H1 2019

Diarrhea – Pipeline by Cosmo Pharmaceuticals NV, H1 2019

Diarrhea – Pipeline by DiscoveryBiomed Inc, H1 2019

Diarrhea – Pipeline by Ferring International Center SA, H1 2019

Diarrhea – Pipeline by GP Pharm SA, H1 2019

Diarrhea – Pipeline by Kaleido Biosciences Inc, H1 2019

Diarrhea – Pipeline by Kuhnil Pharmaceutical Co Ltd, H1 2019

Diarrhea – Pipeline by MyBiotics Pharma Ltd, H1 2019

Diarrhea – Pipeline by Napo Pharmaceuticals Inc, H1 2019

Diarrhea – Pipeline by Nippon Shinyaku Co Ltd, H1 2019

Diarrhea – Pipeline by Novartis AG, H1 2019

Diarrhea – Pipeline by Prokarium Ltd, H1 2019

Diarrhea – Pipeline by Protagonist Therapeutics Inc, H1 2019

Diarrhea – Pipeline by RaQualia Pharma Inc, H1 2019

Diarrhea – Pipeline by RedHill Biopharma Ltd, H1 2019

Diarrhea – Pipeline by RxBio Inc, H1 2019

Diarrhea – Pipeline by Scandinavian Biopharma Holding AB, H1 2019

Diarrhea – Pipeline by Synthetic Biologics Inc, H1 2019

Diarrhea – Pipeline by Syntiron LLC, H1 2019

Diarrhea – Pipeline by Tasly Pharmaceutical Group Co Ltd, H1 2019

Diarrhea – Pipeline by VenatoRx Pharmaceuticals Inc, H1 2019

Diarrhea – Pipeline by Zealand Pharma AS, H1 2019

Diarrhea – Dormant Projects, H1 2019

Diarrhea – Discontinued Products, H1 2019

List of Figures

List of Figures

Number of Products under Development for Diarrhea, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under ...

List of Figures

Number of Products under Development for Diarrhea, H1 2019

Number of Products under Development by Companies, H1 2019

Number of Products under Development by Universities/Institutes, H1 2019

Number of Products by Top 10 Targets, H1 2019

Number of Products by Stage and Top 10 Targets, H1 2019

Number of Products by Top 10 Mechanism of Actions, H1 2019

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019

Number of Products by Routes of Administration, H1 2019

Number of Products by Stage and Routes of Administration, H1 2019

Number of Products by Top 10 Molecule Types, H1 2019

Number of Products by Stage and Top 10 Molecule Types, H1 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports